Otsuka (OTCMKTS:OSUKF – Get Free Report) is expected to announce its resultson Monday, August 3rd. Analysts expect the company to announce earnings of $0.2891 per share and revenue of $2.2495 billion for the quarter.
Otsuka Price Performance
Shares of OTCMKTS OSUKF opened at $20.46 on Monday. The firm has a fifty day moving average of $20.65 and a 200 day moving average of $20.73. Otsuka has a one year low of $19.00 and a one year high of $21.57.
Otsuka Company Profile
Otsuka Holdings Co, Ltd., traded as OSUKF on the OTC Market, is a global healthcare group headquartered in Tokyo, Japan. The company operates through its principal subsidiary, Otsuka Pharmaceutical Co, Ltd., and is primarily engaged in the research, development and commercialization of pharmaceutical products and nutraceuticals. Its product portfolio spans central nervous system therapies, cardiovascular and metabolic treatments, nephrology, and oncology, alongside a range of consumer wellness goods such as nutritional beverages and dietary supplements.
The origins of the Otsuka group date back to 1921 with the founding of its predecessor firm, and in 2008 the current holding company structure was established to streamline governance and strategic direction.
See Also
- Five stocks we like better than Otsuka
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
